Additional file 3: Figure S2. of Haploidentical allograft is superior to matched sibling donor allograft in eradicating pre-transplantation minimal residual disease of AML patients as determined by multiparameter flow cytometry: a retrospective and prospective analysis

Relationship between pre-stem cell transplantation minimal residual disease (pre-SCT MRD), as determined by multiparameter flow cytometry, and transplant outcomes for acute myeloid leukemia patients (nâ =â 99) who underwent HLA-matched sibling donor transplantation in the retrospective study. Estimates of (A) cumulative incidence of non-relapse mortality, (B) cumulative incidence of relapse, (C) leukemia-free survival, and overall survival. MRDneg = negative MRD status; MRDpos = positive MRD status. (DOCX 396 kb)